Filing Details

Accession Number:
0001600620-24-000015
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2024-02-22 16:19:43
Reporting Period:
2023-03-02
Accepted Time:
2024-02-22 16:19:43
Original Submission Date:
2023-03-06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600620 Aurinia Pharmaceuticals Inc. AUPH Pharmaceutical Preparations (2834) 981231763
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1837798 P. Stephen Robertson #140, 14315 - 118 Avenue
Edmonton A0 T5L 4S6
Evp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-03-02 19,644 $8.78 303,122 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.